Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy

AIDS. 2001 Jul 27;15(11):1448-9. doi: 10.1097/00002030-200107270-00019.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / prevention & control*
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Cryptococcosis / drug therapy
  • Cryptococcosis / prevention & control*
  • Fluconazole / therapeutic use
  • Flucytosine / therapeutic use
  • Humans
  • Male

Substances

  • Antifungal Agents
  • Amphotericin B
  • Fluconazole
  • Flucytosine